Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | 0.00% | +6.51% | +2.85% |
Financials (USD)
Sales 2024 * | 3.4M | Sales 2025 * | 4.28M | Capitalization | 7.7M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -22M | EV / Sales 2024 * | 2.26 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
-0.79
x | P/E ratio 2025 * |
-0.96
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Plus Therapeutics, Inc.
1 week | +6.51% | ||
Current month | +3.42% | ||
1 month | -4.26% | ||
3 months | -4.76% | ||
6 months | +12.50% | ||
Current year | +2.85% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.8 | 0.00% | 3,705 |
24-05-02 | 1.8 | +4.65% | 51,657 |
24-05-01 | 1.72 | -1.18% | 5,019 |
24-04-30 | 1.74 | +4.85% | 7,592 |
24-04-29 | 1.66 | -1.78% | 8,726 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.85% | 7.7M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PSTV Stock